NO952635L - Syntetiske peptidderivater og salter derav - Google Patents
Syntetiske peptidderivater og salter deravInfo
- Publication number
- NO952635L NO952635L NO952635A NO952635A NO952635L NO 952635 L NO952635 L NO 952635L NO 952635 A NO952635 A NO 952635A NO 952635 A NO952635 A NO 952635A NO 952635 L NO952635 L NO 952635L
- Authority
- NO
- Norway
- Prior art keywords
- seo
- peptide
- peptide derivatives
- sequence
- ala
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Syntetiske peptidderivater representert ved formelen pl_Rl_P2 hvor P1 er et peptld som har en amlnosyresekvens i SEO ID NO: l ifølge sekvensllsten, eller analoger derav er beskrevet. P2 er et peptid som har en amlnosyresekvens l SEO ID NO: 2 ifølge sekvensllsten, eller analoger derav; R1 angir en linker med en egenskap som ikke interfererer med aktiviteten til hvert peptld P1 og P2 for å binde den N-terminale enden av peptidene P1 og P2. En farmasøytisk sammensetning for behandling av benrelaterte sykdommer omfattende nevnte peptid- derivater, eller et terapeutisk akseptabelt salt derav, eller en farmasøytisk akseptabel bærer. En fremgangsmåte for behandling av benrelaterte sykdommer l et pattedyr omfattende administrering av en effektiv mengde av nevnte peptidderivater, eller terapeutiske akseptable salter derav er også beskrevet. SEKVENSBESKRIVELSE: SEO ID NO: 1: Asp Phe Ser Asp Val Gly Trp Asn Asp Trp Ile Val Ala Pro Pro Gly 1 5 10 15 Tyr SEO ID NO: 2: Ala Ile Val Gin Thr Leu Val Asn Ser Val Asn Ser Lys Ile Pro Lys il 5 10 15 Ala R! omfatter: organiske grupper med karboksylgrupper ved begge ender.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18420394 | 1994-07-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO952635D0 NO952635D0 (no) | 1995-07-03 |
NO952635L true NO952635L (no) | 1996-01-05 |
Family
ID=16149169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952635A NO952635L (no) | 1994-07-04 | 1995-07-03 | Syntetiske peptidderivater og salter derav |
Country Status (8)
Country | Link |
---|---|
US (1) | US5908828A (no) |
EP (1) | EP0691349A3 (no) |
KR (1) | KR960004366A (no) |
AU (1) | AU695241B2 (no) |
CA (1) | CA2153109A1 (no) |
FI (1) | FI953269A (no) |
HU (1) | HUT72068A (no) |
NO (1) | NO952635L (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19548476A1 (de) * | 1995-12-22 | 1997-06-26 | Bioph Biotech Entw Pharm Gmbh | Zielgerichtete Verbindungen mit knorpel- und/oder knocheninduzierender Aktivität |
JP2000119192A (ja) * | 1998-10-09 | 2000-04-25 | Aventis Pharma Ltd | 骨誘導因子アンタゴニスト活性を有する成熟型蛋白質 |
DE10026713A1 (de) * | 2000-05-30 | 2001-12-06 | Walter Sebald | Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta |
GB2369973B (en) * | 2000-12-06 | 2002-12-04 | Open Business Exchange Ltd | Communication Router |
AU2007254824A1 (en) * | 2006-06-02 | 2007-12-13 | Wyeth | Use of proteins and peptides of the TGF-beta superfamily for purification and therapeutic methods |
US7754689B2 (en) | 2006-06-02 | 2010-07-13 | Wyeth Llc | Finger-1 peptide analogs of the TGF-β superfamily |
EP2182888A4 (en) * | 2007-09-04 | 2010-09-08 | Affinergy Inc | METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF GROWTH FACTOR TO A FIBROUS CONJUNCTIVE TISSUE |
US9040046B2 (en) | 2011-01-31 | 2015-05-26 | Kai Xu | Sodium pump antibody agonists and methods of treating heart disease using the same |
WO2024196171A1 (ko) * | 2023-03-21 | 2024-09-26 | 주식회사 아모라이프사이언스 | 골세포 분화용 세포배양기재 및 이의 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284756A (en) * | 1988-10-11 | 1994-02-08 | Lynn Grinna | Heterodimeric osteogenic factor |
KR100259827B1 (ko) * | 1991-11-04 | 2000-06-15 | 브루스 엠. 에이센, 토마스 제이 데스로저 | 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법 |
CA2124422A1 (en) * | 1993-05-27 | 1994-11-28 | Yukio Fujisawa | Heterodimers of tgf-.beta. superfamily |
-
1995
- 1995-06-28 EP EP95110052A patent/EP0691349A3/en not_active Withdrawn
- 1995-06-30 CA CA002153109A patent/CA2153109A1/en not_active Abandoned
- 1995-06-30 US US08/497,599 patent/US5908828A/en not_active Expired - Fee Related
- 1995-06-30 FI FI953269A patent/FI953269A/fi unknown
- 1995-06-30 AU AU23375/95A patent/AU695241B2/en not_active Ceased
- 1995-07-03 HU HU9502018A patent/HUT72068A/hu unknown
- 1995-07-03 NO NO952635A patent/NO952635L/no not_active Application Discontinuation
- 1995-07-04 KR KR1019950019379A patent/KR960004366A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR960004366A (ko) | 1996-02-23 |
CA2153109A1 (en) | 1996-01-05 |
FI953269A0 (fi) | 1995-06-30 |
NO952635D0 (no) | 1995-07-03 |
FI953269A (fi) | 1996-01-05 |
EP0691349A2 (en) | 1996-01-10 |
AU695241B2 (en) | 1998-08-13 |
AU2337595A (en) | 1996-01-18 |
EP0691349A3 (en) | 1997-09-10 |
HUT72068A (en) | 1996-03-28 |
US5908828A (en) | 1999-06-01 |
HU9502018D0 (en) | 1995-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4161522A (en) | Method for blocking allergic responses | |
AU685803B2 (en) | Analogs of peptide YY and uses thereof | |
US4742156A (en) | Peptide antagonists of neurokinin B and opthalmic solutions containing them | |
JPS62159B2 (no) | ||
KR910700262A (ko) | 사람 인슐린 유사체 | |
HK1160778A1 (en) | Pharmaceutical composition comprising an analgesic peptide | |
KR910006324A (ko) | 펩티다아제 및 아이소머라제 억제제 | |
CA2224080A1 (en) | Relaxin-like factor and methods and uses thereof | |
JPH10509428A (ja) | 活性依存性神経栄養因子の神経栄養ペプチド | |
JPS6218560B2 (no) | ||
JPH0680079B2 (ja) | ポリペプチド | |
Fujino et al. | Syntheses and biological activities of analogs of luteinizing hormone releasing hormone (LH-RH) | |
NO952635L (no) | Syntetiske peptidderivater og salter derav | |
EP0317573B1 (en) | Antipyretic and anti-inflammatory peptides | |
AU608846B2 (en) | Cyclic anticoagulant peptides | |
JPH04124198A (ja) | 神経栄養ペプチド誘導体 | |
CA1291592C (en) | Peptide antagonists of neurokinin b | |
EP0156899A1 (en) | Synthetic peptides with egf like activity and pharmaceutical compositions and methods of use | |
CA1157466A (en) | Peptides having thymopoietin-like activity | |
US4397842A (en) | Peptides having thymopoietin-like activity | |
US4550099A (en) | Peptides with nerve-regenerating properties | |
CH645880A5 (de) | Synthetisches antigenaktives polypeptid, verfahren zu dessen herstellung und das polypeptid enthaltendes antigenes mittel sowie arzneimittel. | |
RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
EP0200512B1 (en) | Peptides and their use in therapy | |
DE4341471A1 (de) | Tumor-Nekrose-Faktor-alpha-inaktivierende CDR-Peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |